Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
524.00    4.00 (0.77%)
Bid:
524.00
Ask:
528.00
Spread: 4.00 (0.763%)
Market Cap: £867.04m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Director Dealing

24 Oct 2018 13:30

RNS Number : 0665F
Oakley Capital Investments Limited
24 October 2018
 

24 October 2018

 

 

Oakley Capital Investments Limited

 

Director Dealing

 

Oakley Capital Investments Limited1 (AIM: OCI, the "Company"), was notified today of the following transaction by a Director of the Company:

 

Peter Dubens, a Director of the Company, has purchased 135,096 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at an aggregate price of 184.5 pence per Ordinary Share. As a result, Mr. Dubens is now interested in 9,354,068 Ordinary Shares of the Company, representing 4.567 per cent. of the issued share capital.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Peter Dubens

2

Reason for the notification

 

a)

Position/status

 

Non-Executive Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Oakley Capital Investments Limited

b)

LEI

 

213800KW6MZUK12CQ815

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 1p each

 

 

 

 

BMG670131058

b)

Nature of the transaction

 

 

Acquisition

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

184.5p

 

 

 

135,096

 

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

135,096

 

 

184.5p

e)

Date of the transactions

 

23 October 2018

f)

Place of the transaction

 

London Stock Exchange, AIM

 

 

 

- ends -

 

 

For further information please contact:

 

Oakley Capital Investments Limited

+44 20 7766 6900

Steven Tredget, Investor Relations

 

Greenbrook Communications Ltd

+44 20 7952 2000

Alex Jones / Matthew Goodman / Gina Bell

 

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Gillian Martin / Owen Matthews

 

 

1About Oakley Capital Investments Limited ("OCI")

Oakley Capital Investments Limited is a Bermudian company listed on AIM. OCI seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P., Oakley Capital Private Equity II, Oakley Capital Private Equity III and through co-investment opportunities.

 

LEI Number: 213800KW6MZUK12CQ815

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLZLFLVBFLFBD
Date   Source Headline
1st Aug 20259:06 amRNSConfirmation of Admission to New Listing Category
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:03 amRNSTransaction in Own Shares
30th Jul 20257:01 amRNSNew Listing Category
30th Jul 20257:00 amRNSTrading Update for the 6 Months ended 30 June 2025
29th Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSOakley expands portfolio of heritage brands
30th Jun 20251:42 pmRNSOakley Capital agrees sale of vLex to Clio
24th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSOakley Capital invests in G3
11th Jun 20257:00 amRNSOakley Capital invests in JBMC
9th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSOakley Capital invests in Infravadis
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20257:00 amRNSTotal Voting Rights
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 20257:00 amRNSTrading update for the 3 months ended 31 March 25
30th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20252:02 pmRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.